PLD1 is a key player in cancer stemness and chemoresistance - Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
